Quick Dispatch:
Your glp-1 and crohn's disease Alimentary Pharmacology & Therapeutics | Pharmacology Journal orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 and crohn's disease Alimentary Pharmacology & Therapeutics | Pharmacology Journal ships.
Need Help?
Questions about glp-1 and crohn's disease Alimentary Pharmacology & Therapeutics | Pharmacology Journal, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 and crohn's disease Alimentary Pharmacology & Therapeutics | Pharmacology Journal in your area.
GLP-1 based therapies and disease course of inflammatory bowel disease
22.97
New research published in the Foundation's journal Crohn's & Colitis 360 found that people with IBD who use GLP-1 medications—commonly prescribed for diabetes and obesity—had a lower risk of major heart-related complications
22.04
The Potential for GLP-1s in the Treatment of Crohn's Disease
24.87
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
21.10
GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Crohn's Disease
20.95
GLP-1RAs for IBD
26.08
Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis
20.45
